Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prolonged Intravenous Infusion of β-lactam Antibiotics in Early Septic Patients

NCT05024565 is registered in ClinicalTrials.gov with Qilu Hospital of Shandong University as lead sponsor.

NCT NCT05024565
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05024565 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prolonged Intravenous Infusion of β-lactam Antibiotics in Early Septic Patients
Lead sponsor
Qilu Hospital of Shandong University
Phase
Not applicable
Overall status
Unknown status
Start date
September 20, 2021
Completion date
September 1, 2023
Enrollment
2,600 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis